Navigation Links
Lilly Withdraws Application for Additional U.S. Indication for Cymbalta(R) for Chronic Pain
Date:11/28/2008

ted. They should also talk to their doctor about alcohol consumption. Patients should tell their doctor about all their medicines, including those for migraine, to avoid a potentially life-threatening condition. Taking Duloxetine with NSAID pain relievers, aspirin, or blood thinners may increase bleeding risk. Patients should consult with their doctor before stopping Duloxetine or changing the dose and if they are pregnant or nursing.

Patients taking Duloxetine may experience dizziness or fainting upon standing. The most common side effects of Duloxetine include nausea, dry mouth, sleepiness, and constipation. This is not a complete list of side effects.

For full Patient Information, visit www.Cymbalta.com.

For full Prescribing Information, including Boxed Warning and medication guide, visit www.Cymbalta.com.

About Eli Lilly and Company

Lilly, a leading innovation-driven corporation, is developing a growing portfolio of first-in-class and best-in-class pharmaceutical products by applying the latest research from its own worldwide laboratories and from collaborations with eminent scientific organizations. Headquartered in Indianapolis, Ind., Lilly provides answers -- through medicines and information -- for some of the world's most urgent medical needs. Additional information about Lilly is available at www.lilly.com.

P-LLY

This press release contains forward-looking statements about the potential of Duloxetine for the management of chronic pain, and reflects Lilly's current beliefs. However, as with any pharmaceutical product, there are substantial risks and uncertainties in the process of development and commercialization. There is no guarantee that the resubmission will occur as currently planned,
'/>"/>

SOURCE Eli Lilly and Company
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Daiichi Sankyo and Lilly Respond to Speculation on Status of Prasugrel New Drug Application
2. Lilly and Deciphera Pharmaceuticals Announce Licensing and Collaboration Agreement
3. Lilly Announces Initiation of Second Global Phase III Trial of Investigational Alzheimers Disease Compound
4. Insulin Analogues From Novo Nordisk, Eli Lilly and Sanofi-Aventis Will Drive Growth in the Type 1 Diabetes Drug Market
5. Phase II Data on Lillys Antibody Show It Affects Amyloid Beta, a Protein Believed To Be Associated with Alzheimers Disease
6. FDA Extends Review Period for Daiichi Sankyo, Lilly Investigative Antiplatelet Drug, Prasugrel
7. Lilly and TransPharma Medical Announce Licensing and Development Agreement
8. Lilly Submits Cymbalta(R) Supplemental New Drug Application for Chronic Pain to U.S. Food and Drug Administration
9. Daiichi Sankyo/Eli Lillys Effient and Astrazenecas Ticagrelor May Offer Advantages in the Treatment of Post-Myocardial Infarction
10. Lilly Launches Its First Phase III Trial for Treatment of Alzheimers Disease
11. Lilly and Transition Therapeutics Announce Licensing and Collaboration Agreement
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/6/2015)...  OrthoSpace Ltd. ("OrthoSpace" or "Company") announced today ... its US Investigational Device Exemption (IDE) pivotal study.  ... blinded control study that compares the Company,s InSpace ... repair for the treatment of full thickness massive ... available outside of the United States ...
(Date:7/6/2015)... , July 6, 2015 /CNW/ - The Canadian Pharmacists Association ... immunization strategy to ensure that all Canadians have the ... HPV (human papillomavirus) through immunization. The lack of access ... Canada is needlessly putting the health ... such as HPV, continue to pose a significant threat ...
(Date:7/6/2015)... 6, 2015 Mauna Kea ... multidisciplinary confocal laser endomicroscopy platform, announced today it ... Ministry of Health, Labor and Welfare (MHLW) ... the AQ-Flex 19 miniprobe.   Used ... miniprobe is comprised of a fiber-optic microscope that ...
Breaking Medicine Technology:OrthoSpace Enrolls First Patients in US IDE Study 2CPhA Calls for HPV Strategy for Young Men to Save Lives 2Mauna Kea Technologies Receives Regulatory Approval for the AQ-Flex 19 Miniprobe in Japan 2Mauna Kea Technologies Receives Regulatory Approval for the AQ-Flex 19 Miniprobe in Japan 3
(Date:7/7/2015)... ... July 07, 2015 , ... ... creative design firm, today announced that TimberNook ( http://www.timbernook.com/ ) has ... campaign, content strategy, and marketing launch package for new camp providers. TimberNook ...
(Date:7/7/2015)... Horsham, PA (PRWEB) , ... July 07, 2015 ... ... seasoned financial executive Ellen Purdy as the company’s new Chief Financial Officer, effective ... financial and leadership experience in companies ranging from a multi-billion dollar, global chemical ...
(Date:7/7/2015)... ... July 07, 2015 , ... RadSite™, a leading accreditation agency ... Centers for Medicare and Medicaid Services (CMS), announces that it has updated its ... , The most effective websites are those that provide timely information, frequent updates ...
(Date:7/7/2015)... ... 07, 2015 , ... On May 29, 2015, Health Canada announced that they ... gluten-free claims for gluten free oats and foods that contain them as ingredients. , ... (GFCP) to include gluten-free oat products in Canada,” says Frank Massong, VP of ...
(Date:7/7/2015)... ... July 07, 2015 , ... CareSync proudly announces ... recognized by the White House as a “Champion of Change” for Precision Medicine ... Initiative, the Champions of Change program recognizes Gleason and eight other extraordinary individuals ...
Breaking Medicine News(10 mins):Health News:TimberNook Selects Calypso Communications for PR, Social Media and Content Strategy 2Health News:Office Practicum Announces new CFO 2Health News:RadSite Releases Mobile-friendly Website for Enhanced User Experience 2Health News:RadSite Releases Mobile-friendly Website for Enhanced User Experience 3Health News:Holy Crap Plus Gluten Free Oats Is The First Product With Oats In Canada To Carry The Gluten-Free Certification Program Trademark 2Health News:Holy Crap Plus Gluten Free Oats Is The First Product With Oats In Canada To Carry The Gluten-Free Certification Program Trademark 3Health News:Holy Crap Plus Gluten Free Oats Is The First Product With Oats In Canada To Carry The Gluten-Free Certification Program Trademark 4Health News:White House names Champions of Change for Precision Medicine: CareSync COO Recognized 2Health News:White House names Champions of Change for Precision Medicine: CareSync COO Recognized 3
... and PHILADELPHIA, April 8, 2008 ,GlaxoSmithKline (NYSE: ... warning,letter from the US Food and Drug Administration ... letter follows a routine FDA,inspection of GSK,s reporting ... the inspection primarily relate to omissions from,periodic reports ...
... April 8, 2008 It,s common knowledge,that Americans suffer ... Heart disease is the leading cause of death for ... one in two men and one in three,women will ... we that,scientific studies suggest that resveratrol and antioxidants could,literally ...
... SOUTH PORTLAND, Maine, April 8, 2008 Daniel ... Cross and Blue Shield in Maine. He,replaces Erin ... of,Anthem Blue Cross and Blue Shield in Ohio., ... responsible for the management of,all employer health insurance ...
... 8, 2008 The Estate Vault,Inc. (Pink Sheets: TEVI) is ... the Initiative for Elder Planning Studies to provide its,more than ... Vault as part,of their membership offering., Boyd Soussana, CEO ... part of this growing organization and it was a natural ...
... streamline orientation training for customers, employees, CHARLOTTESVILLE, ... with Silverchair Learning Systems, has launched a,new online ... module,allows for easier, faster training of employees on ... module uses the same methodology as Silverchair,s,eLearning system ...
... Hospital and Sentara Virginia ... Hospital will use SPY routinely, TORONTO, April 8 ... real-time medical imaging and image guidance,systems for the operating ... and Sentara Virginia Beach General,Hospital in Virginia Beach, Virginia ...
Cached Medicine News:Health News:GlaxoSmithKline Confirms Receipt of FDA Letter on Regulatory Reporting 2Health News:Dr. William S. Gruss, M.D., Says That Medical Research Shows You Can Reduce Your Risk of Cancer By Up To 77% and Reverse the Effects of Aging in A CARDIOLOGIST'S GUIDE TO ... ANTI-AGING, ANTIOXIDANTS & RESVERATROL 2Health News:Daniel Corcoran named President of Anthem Blue Cross and Blue Shield in Maine 2Health News:The Initiative for Elder Planning Studies Has Chosen to Include The Estate Vault as Part of Their Membership Offering 2Health News:The Initiative for Elder Planning Studies Has Chosen to Include The Estate Vault as Part of Their Membership Offering 3Health News:Resource Systems and Silverchair Learning Systems Launch CareTracker Online Training Module 2Health News:Virginia's largest Cardiac Surgery program adopts SPY as standard of care 2Health News:Virginia's largest Cardiac Surgery program adopts SPY as standard of care 3Health News:Virginia's largest Cardiac Surgery program adopts SPY as standard of care 4
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
Medicine Products: